AI-Guided Brain Implant for Memory Loss Gets FDA Breakthrough Status

Boston-based Nia Therapeutics has received FDA Breakthrough Device Designation for its Smart Neurostimulation System (SNS), an implantable brain-computer interface (BCI) aimed at treating episodic memory loss in adults with prior moderate-to-severe traumatic brain injury. The designation applies to a patient population with limited treatment options, where no FDA-cleared therapies currently address memory impairment directly.